Cefpodoxime: Clinical Trials

1 trial of Cefpodoxime, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Cefpodoxime: new trials by email Literature Review of Cefpodoxime trials Research Report on Cefpodoxime

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy
Phase 2RecruitingMassachusetts General Hospital3002025-05-052026-09-04

Conditions studied

Anaphylaxis (1)  ·  Drug Hypersensitivity (1)  ·  Hypersensitivity (1)

Sponsors

Massachusetts General Hospital (1)

Countries

United States (1)

Top investigators

David A Khan, MD (1)  ·  Kimberly G Blumenthal, MD, MSc (1)

NIH funding

U01AI184071 (1)